We are live on ! Find out more
PP

PDT Partners Portfolio holdings

AUM $1.69B
1-Year Est. Return 74.01%
This Fund
S&P 500
This Quarter Est. Return
+11.14%
1 Year Est. Return
+74.01%
3 Year Est. Return
+179.69%
5 Year Est. Return
+210.81%
10 Year Est. Return
+1,321.68%
AUM
$1.51B
AUM Growth
+$121M
Cap. Flow
+$19.4M
Cap. Flow %
1.28%
Top 10 Hldgs %
6.27%
Holding
1,018
New
260
Increased
252
Reduced
246
Closed
241

Top Buys

Rank Stock Value
1
STLA icon
Stellantis
STLA
+$10.5M
2
CRL icon
Charles River Laboratories
CRL
+$6.38M
3
MGA icon
Magna International
MGA
+$6.1M
4
IQV icon
IQVIA
IQV
+$5.63M
5
IONS icon
Ionis Pharmaceuticals
IONS
+$5.56M

Top Sells

Rank Stock Value
1
RACE icon
Ferrari
RACE
+$13.8M
2
TSLA icon
Tesla
TSLA
+$7.08M
3
TTC icon
Toro Company
TTC
+$6.88M
4
COHR
Coherent Inc
COHR
+$6.7M
5
GLUU
Glu Mobile Inc.
GLUU
+$6.21M

Sector Composition

Rank Sector Weight
1 Healthcare 23.88%
2 Technology 19.18%
3 Consumer Discretionary 16.07%
4 Industrials 12.4%
5 Financials 8.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AGRO icon
401
Adecoagro
AGRO
$1.48B
$869K 0.06%
86,600
+36,200
+72% +$360K
AAOI icon
402
Applied Optoelectronics
AAOI
$7.85B
$862K 0.06%
101,718
-26,821
-21% -$218K
WT icon
403
WisdomTree
WT
$3.01B
$861K 0.06%
138,859
+60,481
+77% +$399K
STOK icon
404
Stoke Therapeutics
STOK
$1.83B
$860K 0.06%
25,554
+18,897
+284% +$668K
PPD
405
DELISTED
PPD, Inc. Common Stock
PPD
$850K 0.06%
+18,444
New +$833K
ARCO icon
406
Arcos Dorados Holdings
ARCO
$1.75B
$849K 0.06%
144,161
+108,733
+307% +$639K
LYB icon
407
LyondellBasell Industries
LYB
$18.9B
$833K 0.06%
+8,100
New +$877K
VKTX icon
408
Viking Therapeutics
VKTX
$4.05B
$822K 0.05%
137,243
+94,948
+224% +$564K
CSPR
409
DELISTED
Casper Sleep Inc.
CSPR
$812K 0.05%
+98,508
New +$859K
DESP
410
DELISTED
Despegar.com
DESP
$811K 0.05%
61,400
+22,100
+56% +$298K
ZYNE
411
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$804K 0.05%
+151,956
New +$731K
MKTX icon
412
MarketAxess Holdings
MKTX
$4.19B
$797K 0.05%
1,719
-6,188
-78% -$2.95M
GOSS icon
413
Gossamer Bio
GOSS
$97.5M
$793K 0.05%
97,700
-15,120
-13% -$131K
BNFT
414
DELISTED
Benefitfocus, Inc.
BNFT
$789K 0.05%
55,977
+11,394
+26% +$161K
CNST
415
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$788K 0.05%
23,300
-31,519
-57% -$803K
LBTYK icon
416
Liberty Global Class C
LBTYK
$3.27B
$785K 0.05%
29,032
-20,068
-41% -$541K
LE icon
417
Lands' End
LE
$375M
$784K 0.05%
19,090
+10,389
+119% +$284K
PCRX icon
418
Pacira BioSciences
PCRX
$1.04B
$779K 0.05%
+12,843
New +$813K
BMRN icon
419
BioMarin Pharmaceuticals
BMRN
$11.6B
$778K 0.05%
+9,323
New +$739K
ACCO icon
420
Acco Brands
ACCO
$381M
$771K 0.05%
89,290
-1,215
-1% -$10.8K
MTG icon
421
MGIC Investment
MTG
$6.34B
$756K 0.05%
+55,575
New +$798K
AXTA icon
422
Axalta
AXTA
$7.22B
$747K 0.05%
24,509
-156,391
-86% -$4.95M
HUN icon
423
Huntsman Corp
HUN
$2.06B
$745K 0.05%
28,100
+16,300
+138% +$463K
HLIT icon
424
Harmonic Inc
HLIT
$1.23B
$743K 0.05%
87,223
-1,112
-1% -$8.52K
NAGE
425
Niagen Bioscience
NAGE
$257M
$741K 0.05%
+75,184
New +$656K
15 16
17
18 19

Similar funds

ISS
Intesa Sanpaolo SpA. Turin, Italy $1.69B AUM
GAM
Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return
BCM
BlueCrest Capital Management St Helier, Jersey $1.69B AUM 20.01% 1-Year Est. Return
FACM
Forest Avenue Capital Management Miami, Florida $1.69B AUM 104.84% 1-Year Est. Return
TCBWMS
Texas Capital Bank Wealth Management Services Dallas, Texas $1.68B AUM 21.72% 1-Year Est. Return
WAS
Wesleyan Assurance Society Birmingham, United Kingdom $1.69B AUM 28.38% 1-Year Est. Return
SGI
Summit Global Investments Bountiful, Utah $1.69B AUM 12.13% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

PDT Partners's Q2 2021 Portfolio in Review

As of Q2 2021, PDT Partners held 1,018 positions worth $1.51B, up 8.7% from $1.39B the previous quarter. Its ten largest holdings account for 6.3% of the portfolio.

PDT Partners's Q2 2021 filing shows 260 new, 252 increased, 246 reduced and 241 closed positions. Its largest new stake was Stellantis: 559,641 shares worth $11M. The largest sale was Ferrari, an estimated $13.8M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 21% a quarter earlier, followed by Technology and Consumer Discretionary.

  • PDT Partners's largest Q2 2021 buy was Stellantis: 559,641 shares worth $11M.
  • PDT Partners added most to Charles River Laboratories in Q2 2021, an estimated $6.38M increase.
  • PDT Partners's biggest Q2 2021 reduction was Ferrari, cutting an estimated $13.8M.
  • PDT Partners fully exited Tesla in Q2 2021, selling an estimated $7.08M.
  • PDT Partners's ten largest holdings make up 6.3% of its $1.51B portfolio in Q2 2021.
  • PDT Partners opened 260 new positions and closed 241 in Q2 2021.
  • PDT Partners's portfolio value rose 8.7% quarter-over-quarter to $1.51B.

Based on PDT Partners's 13F filing for Q2 2021, filed 16 Aug 2021.